眼部保健品市场－全球产业规模、份额、趋势、机会及预测（依成分类型、症状、配方、地区及竞争格局划分，2021-2031年）

全球眼保健品市场预计将从 2025 年的 30.2 亿美元成长到 2031 年的 51.3 亿美元，复合年增长率为 9.23%。

这些营养补充剂利用玉米黄质、叶黄素、维生素和Omega-3脂肪酸等生物活性成分，旨在改善眼睛生理功能和视力。该领域的成长主要受全球人口老化（老年人罹患老龄化黄斑部病变的风险增加）以及现代生活方式导致数位眼疲劳急剧增加的双重驱动。美国验光协会报告称，到2024年，超过1.04亿美国劳动年龄人口每天将花费超过7小时观看萤幕，这凸显了视觉压力的严重性。这促使人们需要预防性的营养支持，并凸显了该市场的独特性——专注于延长寿命以及与电子设备使用相关的生物学脆弱性。

然而，该市场面临许多挑战：各国产品核可和健康声明的监管环境复杂多元。标籤和成分功效标准各异，为寻求协调全球分销和确保合规性的製造商带来了巨大障碍。这种监管碎片化可能导致产品上市延迟和营运成本增加，最终阻碍创新产品惠及消费者的速度，并限制其在发展中地区的市场渗透。

市场驱动因素

市场成长的关键驱动因素是全球老龄人口的快速成长以及由此导致的老龄化相关性黄斑部病变（AMD）的增加。随着预期寿命的延长，黄斑部劣化的生物学必然性使得营养干预对于保护中心视力至关重要，从而催生了对高剂量抗氧化剂补充剂（例如AREDS2组合药物，这些补充剂经临床验证可延缓疾病进展。美国疾病管制与预防中心（CDC）于2024年5月发布的数据也印证了这一迫切需求：预测85岁及以上成年人中AMD的患病率将达到约46.6%，凸显了为这一不断增长的人群提供治疗性补充剂的紧迫性。

同时，数位产品引起的眼部疲劳日益普遍，正推动消费者行为转变，促使年轻一代更加重视眼部营养。人们普遍暴露于电子设备发出的高能可见光（HEV）蓝光下，导致视觉疲劳和眼睛干涩加剧，促使人们从被动治疗转向预防性护理。 2024年2月，库博光学（CooperVision）报告称，近69%的受访成年人出现与数位产品引起的眼疲劳相关的症状，凸显了此问题的普遍性。长期屈光不正带来的挑战进一步加剧了这个趋势。 2024年10月，美国验光师协会估计，全球儿童和青少年近视盛行率已达30.47%，这意味着视力保健营养补充品市场将持续强劲成长。

市场挑战

全球眼保健品市场面临许多挑战：复杂的法规环境，包括产品核准和健康声明的规定。製造商必须应对碎片化的法律环境，不同地区对标籤要求和成分功效的规定不一致，迫使他们调整行销策略，并针对特定地区重新设计产品。遵守不同国家法律的义务显着增加了合规成本，延长了新产品前置作业时间，阻碍了有效视力支持配方在全球范围内的扩充性，并减缓了新兴市场（这些市场最需要此类产品）对先进眼保健解决方案的接受度。

根据欧洲健康产品製造商联合会 (EHPM) 的说法，2024 年该行业将面临持续的法律不确定性，超过 2000 项植物来源健康声明仍处于搁置状态，等待统一评估。在严重依赖藏红花和越橘等生物活性植物成分的眼科健康领域，这种监管僵局直接阻碍了製造商有效地向消费者传达特定产品益处的能力。因此，企业不愿投资新成分的临床检验，因为他们意识到监管瓶颈可能会阻止他们在包装上做出有依据的健康声明，最终减缓整个市场的成长。

市场趋势

儿童视力健康产品组合的发展正迅速地从一个小众领域发展成为一个经过科学验证的市场区隔。製造商不再局限于普通综合维他命，而是致力于开发专门的、经临床验证的眼科配方，旨在减少儿童早期萤幕暴露对生理的影响。这一趋势的特点是，企业在研发方面投入大量资金，以验证产品对青少年用户的安全性和有效性。凯敏工业公司在2024年10月举行的供应端 West展会上发表的研究结果显示，在一项针对青少年的临床研究中，每日补充玉米黄质和叶黄素可使黄斑色素光密度增加14%。这为青少年的视力保健产品的商业化提供了必要的生物学证据。

同时，兼具眼部和脑部健康益处的促智配方正在改变产品开发格局，这主要得益于消费者对能够同时支持认知压力管理和视觉功能的复合型产品日益增长的需求。这种融合正在加速将认知增强剂和适应原融入传统眼部护理配方中，以对抗长时间专注带来的精神疲劳。对这些跨领域益处的需求也体现在关键促智成分日益增长的受欢迎程度上。根据责任营养委员会 (CRN) 于 2024 年 10 月进行的 2024 年消费者调查，睡茄的使用率已达到使用者整体的 8%，较 2020 年增长了四倍。这证实了市场对缓解压力和认知支持功效的强劲需求，而这些功效正被整合到先进的眼部健康方案中。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球眼保健品市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依成分类型分类（叶黄素和玉米黄素、抗氧化剂、 Omega-3脂肪酸、Coenzyme Q10、类黄酮、α-硫辛酸、虾青素、其他）
  • 依适应症（老龄化黄斑部病变（AMD）、白内障、干眼症、发炎、其他）
  • 按剂型（片剂、胶囊、粉末、软胶囊、液体、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美眼保健品市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲眼保健品市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区眼部保健品市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东与非洲眼部保健品市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲眼保健品市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球眼保健品市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Bausch+Lomb
• Alcon
• Danone SA
• Novartis AG
• Nestle HealthCare Nutrition, Inc.
• DSM
• GlaxoSmithKline
• Pfizer Consumer
• Jamieson
• Jarrow Formulas

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Eye Health Supplements Market is projected to expand from USD 3.02 Billion in 2025 to USD 5.13 Billion by 2031, registering a CAGR of 9.23%. These dietary products, utilizing bioactive components like zeaxanthin, lutein, vitamins, and omega-3 fatty acids, are designed to enhance physiological ocular function and visual acuity. Growth in this sector is largely fueled by an aging global demographic prone to age-related macular degeneration, alongside a dramatic increase in digital eye strain caused by contemporary lifestyle choices. Highlighting the severity of this visual stress, the American Optometric Association reported in 2024 that over 104 million working-age Americans spend more than seven hours daily viewing screens, driving the need for preventative nutritional support and distinguishing this market through its focus on biological vulnerabilities linked to longevity and device use.

However, the market faces a substantial obstacle in the form of a complex regulatory landscape that governs product approvals and health claims across various nations. Discrepancies in standards regarding labeling and ingredient efficacy pose significant hurdles for manufacturers striving to harmonize global distribution and ensure compliance. This fragmentation in regulations can retard product launches and escalate operational expenses, ultimately hindering the pace at which innovations reach consumers and restricting market penetration in developing regions.

Market Driver

A primary catalyst for market growth is the rapid increase in the global geriatric population and the associated rise in age-related macular degeneration (AMD). As life expectancy extends, the biological inevitability of macular degradation necessitates nutritional interventions to protect central vision, creating sustained demand for high-dose antioxidant supplements like the AREDS2 formulation that are clinically proven to slow disease progression. Underscoring this critical need, data released by the Centers for Disease Control and Prevention in May 2024 indicates that the prevalence of AMD among adults aged 85 and older has reached approximately 46.6%, highlighting the urgency for therapeutic supplementation within this growing demographic.

Concurrently, the rising incidence of digital eye strain is altering consumer behavior by pushing younger generations toward proactive ocular nutrition. The widespread exposure to high-energy visible (HEV) blue light from digital devices has led to an increase in visual fatigue and dry eye, prompting a transition from reactive treatments to preventative care. In February 2024, CooperVision reported that nearly 69% of surveyed adults experienced symptoms linked to digital eye strain, illustrating the pervasive nature of this issue. This trend is further reinforced by long-term refractive challenges; the Association of Optometrists estimated in October 2024 that the global prevalence of myopia among children and young people currently stands at 30.47%, signaling a robust future market for vision-supporting nutraceuticals.

Market Challenge

The Global Eye Health Supplements Market encounters a formidable barrier in the form of a complex regulatory environment controlling product approvals and health claims. Manufacturers must navigate a fragmented legal landscape where inconsistent requirements for labeling and ingredient efficacy compel them to alter marketing strategies or reformulate products for specific jurisdictions. This obligation to adhere to disparate national laws significantly raises compliance costs and extends the lead time for new product introductions, thereby stalling the global scalability of effective visual support formulations and slowing the distribution of advanced eye care solutions to emerging markets where they are needed most.

According to the European Federation of Associations of Health Product Manufacturers (EHPM), the industry faced persistent legal uncertainty in 2024 as over 2,000 botanical health claims remained suspended pending a harmonized assessment. For the eye health sector, which depends heavily on bioactive botanical ingredients such as saffron and bilberry, this regulatory stagnation directly prevents manufacturers from effectively communicating specific product benefits to consumers. As a result, companies are reluctant to invest in clinical validation for new ingredients, aware that regulatory bottlenecks may preclude them from making substantiated health claims on packaging, which ultimately dampens overall market growth.

Market Trends

The development of pediatric vision health portfolios is swiftly advancing from a niche category into a scientifically validated market segment. Manufacturers are transitioning beyond general multivitamins to create specialized, clinically substantiated ocular formulations intended to mitigate the physiological effects of early-life screen exposure, a trend marked by significant investment in research to prove safety and efficacy for younger users. In findings presented at SupplySide West in October 2024, Kemin Industries highlighted a clinical study on adolescents showing that daily supplementation with zeaxanthin and lutein led to a 14% increase in macular pigment optical density, offering the biological evidence needed to support the commercialization of targeted vision products for teenagers.

Simultaneously, the incorporation of nootropics for dual eye-brain health benefits is transforming product development as consumers increasingly demand functional stacks that support both cognitive stress management and visual performance. This convergence drives the inclusion of cognitive enhancers and adaptogens into traditional eye care formulas to address the mental fatigue linked to prolonged focus. The demand for these cross-category benefits is reflected in the rising popularity of key nootropic ingredients; according to the Council for Responsible Nutrition's '2024 Consumer Survey' from October 2024, usage of ashwagandha reached 8% among all supplement users, representing a four-fold increase since 2020 and indicating a strong market appetite for the stress-relief and cognitive support features now being integrated into advanced eye health regimens.

Key Market Players

• Bausch + Lomb
• Alcon
• Danone S.A
• Novartis AG
• Nestle HealthCare Nutrition, Inc.
• DSM
• GlaxoSmithKline
• Pfizer Consumer
• Jamieson
• Jarrow Formulas

Report Scope

In this report, the Global Eye Health Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Eye Health Supplements Market, By Ingredient Type

• Lutein & Zeaxanthin
• Antioxidants
• Omega-3 Fatty Acids
• Coenzyme Q10
• Flavonoids
• Alpha-Lipoic Acid
• Astaxanthin
• Others

Eye Health Supplements Market, By Indication

• Age-related Macular Degeneration (AMD)
• Cataract
• Dry Eye Syndrome
• Inflammation
• Others

Eye Health Supplements Market, By Formulation

• Tablets
• Capsules
• Powder
• Softgels
• Liquid
• Others

Eye Health Supplements Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Eye Health Supplements Market.

Available Customizations:

Global Eye Health Supplements Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Eye Health Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Ingredient Type (Lutein & Zeaxanthin, Antioxidants, Omega-3 Fatty Acids, Coenzyme Q10, Flavonoids, Alpha-Lipoic Acid, Astaxanthin, Others)
  • 5.2.2. By Indication (Age-related Macular Degeneration (AMD), Cataract, Dry Eye Syndrome, Inflammation, Others)
  • 5.2.3. By Formulation (Tablets, Capsules, Powder, Softgels, Liquid, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Eye Health Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Ingredient Type
  • 6.2.2. By Indication
  • 6.2.3. By Formulation
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Eye Health Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Ingredient Type
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Formulation
  • 6.3.2. Canada Eye Health Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Ingredient Type
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Formulation
  • 6.3.3. Mexico Eye Health Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Ingredient Type
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Formulation

7. Europe Eye Health Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Ingredient Type
  • 7.2.2. By Indication
  • 7.2.3. By Formulation
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Eye Health Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Ingredient Type
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Formulation
  • 7.3.2. France Eye Health Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Ingredient Type
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Formulation
  • 7.3.3. United Kingdom Eye Health Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Ingredient Type
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Formulation
  • 7.3.4. Italy Eye Health Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Ingredient Type
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Formulation
  • 7.3.5. Spain Eye Health Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Ingredient Type
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Formulation

8. Asia Pacific Eye Health Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Ingredient Type
  • 8.2.2. By Indication
  • 8.2.3. By Formulation
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Eye Health Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Ingredient Type
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Formulation
  • 8.3.2. India Eye Health Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Ingredient Type
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Formulation
  • 8.3.3. Japan Eye Health Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Ingredient Type
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Formulation
  • 8.3.4. South Korea Eye Health Supplements Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Ingredient Type
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Formulation
  • 8.3.5. Australia Eye Health Supplements Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Ingredient Type
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Formulation

9. Middle East & Africa Eye Health Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Ingredient Type
  • 9.2.2. By Indication
  • 9.2.3. By Formulation
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Eye Health Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Ingredient Type
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Formulation
  • 9.3.2. UAE Eye Health Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Ingredient Type
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Formulation
  • 9.3.3. South Africa Eye Health Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Ingredient Type
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Formulation

10. South America Eye Health Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Ingredient Type
  • 10.2.2. By Indication
  • 10.2.3. By Formulation
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Eye Health Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Ingredient Type
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Formulation
  • 10.3.2. Colombia Eye Health Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Ingredient Type
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Formulation
  • 10.3.3. Argentina Eye Health Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Ingredient Type
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Formulation

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Eye Health Supplements Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bausch + Lomb
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Alcon
• 15.3. Danone S.A
• 15.4. Novartis AG
• 15.5. Nestle HealthCare Nutrition, Inc.
• 15.6. DSM
• 15.7. GlaxoSmithKline
• 15.8. Pfizer Consumer
• 15.9. Jamieson
• 15.10. Jarrow Formulas

16. Strategic Recommendations

17. About Us & Disclaimer